Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its Board of Directors has named Daniel O’Day...
Up to date
Appointments
William Anderson, currently CEO of Genentech, will be appointed CEO Roche Pharmaceuticals effective 1 January...
Forbion, a European life science venture capital firm, today announces that Carlo Incerti, M.D., will be...
Merck today announced the appointment of Jasper Bos as the new Managing Director of its strategic corporate...
Bergenbio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, oral, selective...
Hox Therapeutics has announced the appointment of Dr Karl Keegan as Chief Executive Officer.
Share
